Business UpdateJun 12, 2026, 03:34 PM
Cosmos Health Cana Labs Secures 253,657 Unit Manufacturing Orders
AI Summary
Cosmos Health Inc. announced that its wholly-owned subsidiary, Cana Laboratories, has secured new contract manufacturing orders from Nassington and Verisfield. These orders amount to a combined 253,657 units of various medicines and pharmaceutical products. The CEO stated that these orders reflect strong demand for Cana's manufacturing capabilities and contribute to building a diversified manufacturing business for long-term shareholder value.
Key Highlights
- Cosmos Health's subsidiary, Cana Laboratories, received new contract manufacturing orders.
- Orders total 253,657 units across various pharmaceutical products.
- Contracts secured from established pharmaceutical partners Nassington and Verisfield.
- Products include Gritse oral solutions, Fungofort spray, Paco-4 tablets, and dexamethasone.
- CEO Greg Siokas highlighted demand for Cana's capabilities and diversified manufacturing.
Price Impact
More from COSM